All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

93

Reset

93 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • DNA VaccinePhase 22 trials

    NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)

  • DOC1021Phase 22 trials

    Diakonos Oncology Corporation · Glioblastoma (GBM), Refractory Melanoma

  • GI-102Phase 22 trials

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)

  • JMT108Phase 22 trials

    Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors

  • KB707Phase 22 trials

    Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV

  • LM103 TILsPhase 22 trials

    Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer

  • QuavonlimabMK-1308Phase 22 trials

    Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer

  • RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials

    Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc

  • TCC1727Phase 22 trials

    Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)

  • TQB2916Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer

  • TRK-950Phase 22 trials

    Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • AMT-253Phase 21 trial

    Multitude Therapeutics Inc. · Malignant Melanoma, Advanced Solid Tumors

  • AU-007Phase 21 trial

    Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • BI-1607Phase 21 trial

    BioInvent International AB · Melanoma Metastatic, Melanoma of Skin, Melanoma BRAF V600E/K Mutated

  • BI-1808Phase 21 trial

    BioInvent International AB · Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma

  • CJRB-101Phase 21 trial

    CJ Bioscience, Inc. · NSCLC, HNSCC, Melanoma

  • DYP688Phase 21 trial

    Novartis · Metastatic Uveal Melanoma

  • ENV-501Phase 21 trial

    Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer

  • EVX-01Phase 21 trial

    Evaxion Biotech A/S · Melanoma Stage IV, Unresectable Melanoma

  • Fixed cemiplimabPhase 21 trial

    Regeneron · Melanoma

  • GEN1042Phase 21 trial

    Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • GIM-531Phase 21 trial

    Georgiamune Inc · Melanoma Stage IV, Solid Tumor

  • GM103Phase 21 trial

    GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer

  • HX009Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma

  • IOV-3001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Ocular Melanoma

  • IOV-4001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer

  • IPN01194Phase 21 trial

    Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma

  • KVA12123Phase 21 trial

    Kineta Inc. · Cancer, Solid Tumor, Melanoma

  • LTT462Phase 21 trial

    Novartis · Melanoma

  • N17350Phase 21 trial

    Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • OKI-179Phase 21 trial

    OnKure, Inc. · RAS Mutation, NRAS Gene Mutation, Melanoma

  • OPM-101Phase 21 trial

    Oncodesign Precision Medicine · Advanced Melanoma

  • OR502Phase 21 trial

    OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm

  • PRTX007Phase 21 trial

    Primmune Therapeutics, Inc. · Melanoma Stage III

  • RBP-01Phase 21 trial

    ReBio Pharma · Uveal Melanoma

  • RLY-8161Phase 21 trial

    Relay Therapeutics, Inc. · Advanced NRAS-Mutant Melanoma, Advanced NRAS-Mutant Solid Tumors, NRAS Mutation

  • ST-067Phase 21 trial

    Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma

  • ST101Phase 21 trial

    Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer

  • VMD-102Single agentPhase 21 trial

    VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)

  • XP-102Phase 21 trial

    Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma

NewerPage 2 of 2

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.